PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.
%A Oduyebo, Titilope; Rauh-Hain, Alejandro J.; Meserve, Emily E.; Seidman, Michael A.; Hinchcliff, Emily; George, Suzanne; Quade, Bradley; Nucci, Marisa R.; Del Carmen, Marcela G.; Muto, Michael G.
%T The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
%J Gynecologic oncology, vol. 132, no. 2, pp. 360-365
%D 02/2014
%V 132
%N 2
%M eng
%B To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).
%K Adult, Disease-Free Survival, Female, Humans, Leiomyoma, Leiomyosarcoma, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Seeding, Peritoneal Neoplasms, Prognosis, Reoperation, Uterine Neoplasms
%P 360
%L 365
%Y 10.1016/j.ygyno.2013.11.024
%W PHY
%G AUTHOR
%R 2014......132..360O

@Article{Oduyebo2014,
author="Oduyebo, Titilope
and Rauh-Hain, Alejandro J.
and Meserve, Emily E.
and Seidman, Michael A.
and Hinchcliff, Emily
and George, Suzanne
and Quade, Bradley
and Nucci, Marisa R.
and Del Carmen, Marcela G.
and Muto, Michael G.",
title="The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.",
journal="Gynecologic oncology",
year="2014",
month="Feb",
day="01",
volume="132",
number="2",
pages="360--365",
keywords="Adult",
keywords="Disease-Free Survival",
keywords="Female",
keywords="Humans",
keywords="Leiomyoma",
keywords="Leiomyosarcoma",
keywords="Middle Aged",
keywords="Neoplasm Recurrence, Local",
keywords="Neoplasm Seeding",
keywords="Peritoneal Neoplasms",
keywords="Prognosis",
keywords="Reoperation",
keywords="Uterine Neoplasms",
abstract="To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).",
issn="1095-6859",
doi="10.1016/j.ygyno.2013.11.024",
url="http://www.ncbi.nlm.nih.gov/pubmed/24296345",
language="eng"
}

%0 Journal Article
%T The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
%A Oduyebo, Titilope
%A Rauh-Hain, Alejandro J.
%A Meserve, Emily E.
%A Seidman, Michael A.
%A Hinchcliff, Emily
%A George, Suzanne
%A Quade, Bradley
%A Nucci, Marisa R.
%A Del Carmen, Marcela G.
%A Muto, Michael G.
%J Gynecologic oncology
%D 2014
%8 Feb 01
%V 132
%N 2
%@ 1095-6859
%G eng
%F Oduyebo2014
%X To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).
%K Adult
%K Disease-Free Survival
%K Female
%K Humans
%K Leiomyoma
%K Leiomyosarcoma
%K Middle Aged
%K Neoplasm Recurrence, Local
%K Neoplasm Seeding
%K Peritoneal Neoplasms
%K Prognosis
%K Reoperation
%K Uterine Neoplasms
%U http://dx.doi.org/10.1016/j.ygyno.2013.11.024
%U http://www.ncbi.nlm.nih.gov/pubmed/24296345
%P 360-365

PT Journal
AU Oduyebo, T
   Rauh-Hain, AJ
   Meserve, EE
   Seidman, MA
   Hinchcliff, E
   George, S
   Quade, B
   Nucci, MR
   Del Carmen, MG
   Muto, MG
TI The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
SO Gynecologic oncology
JI Gynecol. Oncol.
PD Feb
PY 2014
BP 360
EP 365
VL 132
IS 2
DI 10.1016/j.ygyno.2013.11.024
LA eng
DE Adult; Disease-Free Survival; Female; Humans; Leiomyoma; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Peritoneal Neoplasms; Prognosis; Reoperation; Uterine Neoplasms
AB To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).
ER

PMID- 24296345
OWN - NLM
STAT- MEDLINE
DA  - 20140217
DCOM- 20140411
IS  - 1095-6859 (Electronic)
IS  - 0090-8258 (Linking)
VI  - 132
IP  - 2
DP  - 2014 Feb
TI  - The value of re-exploration in patients with inadvertently morcellated uterine
      sarcoma.
PG  - 360-5
LID - 10.1016/j.ygyno.2013.11.024 [doi]
LID - S0090-8258(13)01351-6 [pii]
AB  - OBJECTIVE: To describe the role of immediate re-exploration in patients with
      inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors 
      of uncertain malignant potential (STUMP). METHODS: All patients with ULMS/STUMP
      who were managed or referred to the participating institutions from January 2005 
      to January 2012 following minimally invasive gynecology surgery with morcellation
      were detected through the pathology database. The diagnosis was confirmed by
      gynecologic-pathologists following post-surgery pathology review. RESULTS:
      Twenty-one patients with the diagnosis of ULMS (N = 15) and STUMP (N = 6) after
      morcellation were identified. The median age of occurrence was 46 years (range,
      25-58 years). Median follow-up duration was 27 months (range, 1.8-93.1 months).
      None of the 21 patients had documented evidence of extra-uterine disease at the
      time of original surgery. Ultimately 12 patients were immediately re-explored to 
      complete staging. The median time to the staging surgery was 33 days (range
      15-118 days). Two (28.5%) out of seven patients with presumed stage I ULMS and
      one (25%) out of four patients with presumed stage I STUMP had significant
      findings of disseminated intraperitoneal disease detected at immediate surgical
      re-exploration. One of the 8 patients with confined early ULMS and STUMP at the
      second surgery had intraperitoneal recurrence, while the remaining 7 patients
      have had no recurrence and remain disease free. CONCLUSION: Surgical
      re-exploration is likely to show findings of disseminated peritoneal sarcomatosis
      in a significant number of patients diagnosed with ULMS after a morcellation
      procedure. Findings from re-exploration can contribute to the knowledge of
      natural history of morcellated ULMS/STUMP and allow for accurate prognostication.
CI  - Copyright (c) 2013 Elsevier Inc. All rights reserved.
FAU - Oduyebo, Titilope
AU  - Oduyebo T
AD  - Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA,
      United States; Division of Gynecologic Oncology, Vincent Obstetrics and
      Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard
      School of Medicine, Boston, MA, United States.
FAU - Rauh-Hain, Alejandro J
AU  - Rauh-Hain AJ
AD  - Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology,
      Massachusetts General Hospital, Boston, MA, United States; Harvard School of
      Medicine, Boston, MA, United States.
FAU - Meserve, Emily E
AU  - Meserve EE
AD  - Division of Women's & Perinatal Pathology, Department of Pathology & Laboratory
      Medicine, Brigham & Women's Hospital, United States; Harvard School of Medicine, 
      Boston, MA, United States.
FAU - Seidman, Michael A
AU  - Seidman MA
AD  - Division of Women's & Perinatal Pathology, Department of Pathology & Laboratory
      Medicine, Brigham & Women's Hospital, United States; Harvard School of Medicine, 
      Boston, MA, United States.
FAU - Hinchcliff, Emily
AU  - Hinchcliff E
AD  - Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA,
      United States; Division of Gynecologic Oncology, Vincent Obstetrics and
      Gynecology, Massachusetts General Hospital, Boston, MA, United States; Harvard
      School of Medicine, Boston, MA, United States.
FAU - George, Suzanne
AU  - George S
AD  - Harvard School of Medicine, Boston, MA, United States; Dana Farber Cancer
      Institute, Boston, MA, United States.
FAU - Quade, Bradley
AU  - Quade B
AD  - Division of Women's & Perinatal Pathology, Department of Pathology & Laboratory
      Medicine, Brigham & Women's Hospital, United States; Harvard School of Medicine, 
      Boston, MA, United States.
FAU - Nucci, Marisa R
AU  - Nucci MR
AD  - Division of Women's & Perinatal Pathology, Department of Pathology & Laboratory
      Medicine, Brigham & Women's Hospital, United States; Harvard School of Medicine, 
      Boston, MA, United States.
FAU - Del Carmen, Marcela G
AU  - Del Carmen MG
AD  - Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology,
      Massachusetts General Hospital, Boston, MA, United States; Harvard School of
      Medicine, Boston, MA, United States.
FAU - Muto, Michael G
AU  - Muto MG
AD  - Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA,
      United States; Harvard School of Medicine, Boston, MA, United States. Electronic 
      address: [email protected]
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20131201
PL  - United States
TA  - Gynecol Oncol
JT  - Gynecologic oncology
JID - 0365304
SB  - IM
MH  - Adult
MH  - Disease-Free Survival
MH  - Female
MH  - Humans
MH  - Leiomyoma/pathology/surgery
MH  - Leiomyosarcoma/pathology/*surgery
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local/*pathology/*surgery
MH  - *Neoplasm Seeding
MH  - Peritoneal Neoplasms/*pathology/*surgery
MH  - Prognosis
MH  - Reoperation
MH  - Uterine Neoplasms/pathology/*surgery
OTO - NOTNLM
OT  - Fibroids
OT  - Leiomyoma
OT  - Leiomyosarcoma
OT  - Morcellation
OT  - Smooth muscle tumor of uncertain potential
OT  - Uterine
EDAT- 2013/12/04 06:00
MHDA- 2014/04/12 06:00
CRDT- 2013/12/04 06:00
PHST- 2013/08/30 [received]
PHST- 2013/11/16 [revised]
PHST- 2013/11/21 [accepted]
PHST- 2013/12/01 [aheadofprint]
AID - S0090-8258(13)01351-6 [pii]
AID - 10.1016/j.ygyno.2013.11.024 [doi]
PST - ppublish
SO  - Gynecol Oncol. 2014 Feb;132(2):360-5. doi: 10.1016/j.ygyno.2013.11.024. Epub 2013
      Dec 1.
TY  - JOUR
AU  - Oduyebo, Titilope
AU  - Rauh-Hain, Alejandro J.
AU  - Meserve, Emily E.
AU  - Seidman, Michael A.
AU  - Hinchcliff, Emily
AU  - George, Suzanne
AU  - Quade, Bradley
AU  - Nucci, Marisa R.
AU  - Del Carmen, Marcela G.
AU  - Muto, Michael G.
PY  - 2014/Feb/01
TI  - The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
T2  - Gynecol. Oncol.
JO  - Gynecologic oncology
SP  - 360
EP  - 365
VL  - 132
IS  - 2
KW  - Adult
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Leiomyoma
KW  - Leiomyosarcoma
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Seeding
KW  - Peritoneal Neoplasms
KW  - Prognosis
KW  - Reoperation
KW  - Uterine Neoplasms
N2  - To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).
SN  - 1095-6859
UR  - http://dx.doi.org/10.1016/j.ygyno.2013.11.024
UR  - http://www.ncbi.nlm.nih.gov/pubmed/24296345
ID  - Oduyebo2014
ER  - 
<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Oduyebo2014</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2014</b:Year>
<b:Month>Feb</b:Month>
<b:Day>01</b:Day>
<b:PeriodicalName>Gynecologic oncology</b:PeriodicalName>
<b:Volume>132</b:Volume>
<b:Issue>2</b:Issue>
<b:Pages>360-365</b:Pages>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Oduyebo</b:Last><b:First>Titilope</b:First></b:Person>
<b:Person><b:Last>Rauh-Hain</b:Last><b:First>Alejandro</b:First><b:Middle>J</b:Middle></b:Person>
<b:Person><b:Last>Meserve</b:Last><b:First>Emily</b:First><b:Middle>E</b:Middle></b:Person>
<b:Person><b:Last>Seidman</b:Last><b:First>Michael</b:First><b:Middle>A</b:Middle></b:Person>
<b:Person><b:Last>Hinchcliff</b:Last><b:First>Emily</b:First></b:Person>
<b:Person><b:Last>George</b:Last><b:First>Suzanne</b:First></b:Person>
<b:Person><b:Last>Quade</b:Last><b:First>Bradley</b:First></b:Person>
<b:Person><b:Last>Nucci</b:Last><b:First>Marisa</b:First><b:Middle>R</b:Middle></b:Person>
<b:Person><b:Last>Del Carmen</b:Last><b:First>Marcela</b:First><b:Middle>G</b:Middle></b:Person>
<b:Person><b:Last>Muto</b:Last><b:First>Michael</b:First><b:Middle>G</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.</b:Title>
 <b:ShortTitle>Gynecol. Oncol.</b:ShortTitle>
<b:Comments>To describe the role of immediate re-exploration in patients with inadvertently morcellated uterine leiomyosarcoma (ULMS) and smooth muscle tumors of uncertain malignant potential (STUMP).</b:Comments>
</b:Source>
</b:Sources>